In particular, the involvement of tankyrases in Wnt signalling (related to tumourigenesis) and glucose homeostasis (related to diabetes) promises advances for targeting tankyrases for therapeutic interventions, as demonstrated by the pre-clinical experimentation of tankyrase inhibitors for treatment of CRC [10,170,181–186]. Here, TNKS is linked to colorectal carcinoma.